GENE ONLINE|News &
Opinion
Blog

Oncology
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
JPM 2024: Pfizer’s Strategic Moves in the Obesity Drug Market and BioNTech’s Oncology Pipeline Expansion
2024-01-10
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Merger Announced Between Immunome and Morphimmune
2023-07-05
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
GeneOnline’s Weekly News Highlights: June 19-23
2023-06-26
Pyramid Biosciences Bets $1B on Oncology Drug
2023-04-17
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
FDA Drops New Oncology Development Guidelines
2022-10-18
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
1 2 3 6
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top